Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
by
Law, Gordon
, Desai, Mehul
, Perkovic, Vlado
, Erondu, Ngozi
, Neal, Bruce
, Mahaffey, Kenneth W
, Matthews, David R
, Fulcher, Greg
, Shaw, Wayne
, de Zeeuw, Dick
in
Aged
/ Albuminuria - complications
/ Amputation
/ Amputation, Surgical - statistics & numerical data
/ Antidiabetics
/ Blood glucose
/ Blood pressure
/ Body weight
/ Canagliflozin - adverse effects
/ Canagliflozin - therapeutic use
/ Cardiovascular disease
/ Cardiovascular diseases
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular Diseases - mortality
/ Cardiovascular Diseases - prevention & control
/ Cerebral infarction
/ Clinical trials
/ Diabetes
/ Diabetes mellitus
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - physiopathology
/ Disease Progression
/ Drug dosages
/ FDA approval
/ Female
/ Foot - surgery
/ Glomerular filtration rate
/ Glomerular Filtration Rate - drug effects
/ Health risk assessment
/ Heart attacks
/ Heart failure
/ Hospitalization - statistics & numerical data
/ Humans
/ Hypoglycemic Agents - adverse effects
/ Hypoglycemic Agents - therapeutic use
/ Kidney diseases
/ Kidney Diseases - etiology
/ Kidney Diseases - mortality
/ Kidney transplantation
/ Male
/ Medicine
/ Metatarsus
/ Middle Aged
/ Myocardial infarction
/ Side effects
/ Sodium
/ Sodium-glucose cotransporter
/ Statistical analysis
/ Stroke
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
by
Law, Gordon
, Desai, Mehul
, Perkovic, Vlado
, Erondu, Ngozi
, Neal, Bruce
, Mahaffey, Kenneth W
, Matthews, David R
, Fulcher, Greg
, Shaw, Wayne
, de Zeeuw, Dick
in
Aged
/ Albuminuria - complications
/ Amputation
/ Amputation, Surgical - statistics & numerical data
/ Antidiabetics
/ Blood glucose
/ Blood pressure
/ Body weight
/ Canagliflozin - adverse effects
/ Canagliflozin - therapeutic use
/ Cardiovascular disease
/ Cardiovascular diseases
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular Diseases - mortality
/ Cardiovascular Diseases - prevention & control
/ Cerebral infarction
/ Clinical trials
/ Diabetes
/ Diabetes mellitus
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - physiopathology
/ Disease Progression
/ Drug dosages
/ FDA approval
/ Female
/ Foot - surgery
/ Glomerular filtration rate
/ Glomerular Filtration Rate - drug effects
/ Health risk assessment
/ Heart attacks
/ Heart failure
/ Hospitalization - statistics & numerical data
/ Humans
/ Hypoglycemic Agents - adverse effects
/ Hypoglycemic Agents - therapeutic use
/ Kidney diseases
/ Kidney Diseases - etiology
/ Kidney Diseases - mortality
/ Kidney transplantation
/ Male
/ Medicine
/ Metatarsus
/ Middle Aged
/ Myocardial infarction
/ Side effects
/ Sodium
/ Sodium-glucose cotransporter
/ Statistical analysis
/ Stroke
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
by
Law, Gordon
, Desai, Mehul
, Perkovic, Vlado
, Erondu, Ngozi
, Neal, Bruce
, Mahaffey, Kenneth W
, Matthews, David R
, Fulcher, Greg
, Shaw, Wayne
, de Zeeuw, Dick
in
Aged
/ Albuminuria - complications
/ Amputation
/ Amputation, Surgical - statistics & numerical data
/ Antidiabetics
/ Blood glucose
/ Blood pressure
/ Body weight
/ Canagliflozin - adverse effects
/ Canagliflozin - therapeutic use
/ Cardiovascular disease
/ Cardiovascular diseases
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular Diseases - mortality
/ Cardiovascular Diseases - prevention & control
/ Cerebral infarction
/ Clinical trials
/ Diabetes
/ Diabetes mellitus
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - physiopathology
/ Disease Progression
/ Drug dosages
/ FDA approval
/ Female
/ Foot - surgery
/ Glomerular filtration rate
/ Glomerular Filtration Rate - drug effects
/ Health risk assessment
/ Heart attacks
/ Heart failure
/ Hospitalization - statistics & numerical data
/ Humans
/ Hypoglycemic Agents - adverse effects
/ Hypoglycemic Agents - therapeutic use
/ Kidney diseases
/ Kidney Diseases - etiology
/ Kidney Diseases - mortality
/ Kidney transplantation
/ Male
/ Medicine
/ Metatarsus
/ Middle Aged
/ Myocardial infarction
/ Side effects
/ Sodium
/ Sodium-glucose cotransporter
/ Statistical analysis
/ Stroke
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Journal Article
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017
Request Book From Autostore
and Choose the Collection Method
Overview
In this report of two randomized trials, patients with type 2 diabetes at risk for cardiovascular disease received the sodium–glucose cotransporter 2 inhibitor canagliflozin or placebo and were followed for 188 weeks. Canagliflozin reduced the risk of cardiovascular events.
Publisher
Massachusetts Medical Society
Subject
/ Amputation, Surgical - statistics & numerical data
/ Canagliflozin - adverse effects
/ Canagliflozin - therapeutic use
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular Diseases - mortality
/ Cardiovascular Diseases - prevention & control
/ Diabetes
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - physiopathology
/ Female
/ Glomerular Filtration Rate - drug effects
/ Hospitalization - statistics & numerical data
/ Humans
/ Hypoglycemic Agents - adverse effects
/ Hypoglycemic Agents - therapeutic use
/ Male
/ Medicine
/ Sodium
/ Sodium-glucose cotransporter
/ Stroke
This website uses cookies to ensure you get the best experience on our website.